BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19703000)

  • 21. Drug-induced lichenoid dermatitis with histopathologic features of mycosis fungoides in a patient with psoriasis.
    Wu J; Vender R; Jambrosic J
    J Cutan Med Surg; 2010; 14(6):307-9. PubMed ID: 21084025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sarcoid-like granulomatous disease following etanercept treatment for RA.
    Kudrin A; Chilvers ER; Ginawi A; Hazleman BL; Griffiths MH; Thiru S; Ostor AJ
    J Rheumatol; 2007 Mar; 34(3):648-9. PubMed ID: 17343313
    [No Abstract]   [Full Text] [Related]  

  • 23. Severe psoriasis pustulosa palmaris et plantaris (Barber-Königsbeck) treated successfully with soluble tumour necrosis factor receptor fusion protein (etanercept).
    Kasche A; Pfab F; Hein R; Athanasiadis GI; Ollert M; Ring J; Eberlein-König B
    J Eur Acad Dermatol Venereol; 2007 Feb; 21(2):255-7. PubMed ID: 17243968
    [No Abstract]   [Full Text] [Related]  

  • 24. Primary cutaneous aspergillosis complicating tumor necrosis factor-α blockade therapy in a patient with psoriasis.
    Osório F; Magina S; Azevedo F
    Actas Dermosifiliogr; 2012 Dec; 103(10):939-41. PubMed ID: 23182382
    [No Abstract]   [Full Text] [Related]  

  • 25. [Granuloma formation in test and treatment sites caused by intracutaneously administered, injectable collagen].
    Schurig V; Konz B; Ring J; Dorn M
    Hautarzt; 1986 Jan; 37(1):42-5. PubMed ID: 2936700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etanercept in infants: suberythrodermic, recalcitrant psoriasis in a 22 month-old child successfully treated with etanercept.
    Fabrizi G; Guerriero C; Pagliarello C
    Eur J Dermatol; 2007; 17(3):245. PubMed ID: 17478389
    [No Abstract]   [Full Text] [Related]  

  • 27. Peripheral mononeuropathy with etanercept use: case report.
    Hanaoka BY; Libecco J; Rensel M; Hajj-Ali RA
    J Rheumatol; 2008 Jan; 35(1):182. PubMed ID: 18176996
    [No Abstract]   [Full Text] [Related]  

  • 28. Angiokeratoma induced by injection of etanercept for psoriasis.
    Bathelier E; Gunera-Saad N; Bérard F; Nicolas JF
    J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S124-5. PubMed ID: 19119125
    [No Abstract]   [Full Text] [Related]  

  • 29. Recurrent varicella in an adult psoriasis patient treated with etanercept.
    Becart S; Segaert S
    Dermatology; 2008; 217(3):260-1. PubMed ID: 18667825
    [No Abstract]   [Full Text] [Related]  

  • 30. Etanercept-induced lichenoid reaction pattern in psoriasis.
    Bovenschen HJ; Kop EN; Van De Kerkhof PC; Seyger MM
    J Dermatolog Treat; 2006; 17(6):381-3. PubMed ID: 17853314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Etanercept-associated pulmonary granulomatous inflammation in patients with rheumatoid arthritis.
    Ognenovski VM; Ojo TC; Fox DA
    J Rheumatol; 2008 Nov; 35(11):2279-82. PubMed ID: 19004058
    [No Abstract]   [Full Text] [Related]  

  • 32. First fatal case of systemic suppurative/necrotizing granulomatous disease following etanercept therapy for psoriasis.
    Turashvili G; Farmer P
    J Dermatolog Treat; 2015 Apr; 26(2):124-7. PubMed ID: 24646144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etanercept-induced injection site reactions: potential pathomechanisms and clinical assessment.
    Batycka-Baran A; Flaig M; Molin S; Ruzicka T; Prinz JC
    Expert Opin Drug Saf; 2012 Nov; 11(6):911-21. PubMed ID: 22998733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of Crohn disease in a patient on etanercept for psoriasis.
    Ahmad K; Rogers S
    Br J Dermatol; 2007 Aug; 157(2):396. PubMed ID: 17573878
    [No Abstract]   [Full Text] [Related]  

  • 35. [Neutropenia and thrombocytopenia in a patient presenting psoriasis treated with etanercept].
    Lahbabi I; Adamski H; Le Jean S; Cannieux V; Polard E; Chevrant-Breton J
    Ann Dermatol Venereol; 2008 May; 135(5):409-10. PubMed ID: 18457732
    [No Abstract]   [Full Text] [Related]  

  • 36. Granulomatous hepatitis associated with etanercept therapy.
    Farah M; Al Rashidi A; Owen DA; Yoshida EM; Reid GD
    J Rheumatol; 2008 Feb; 35(2):349-51. PubMed ID: 18260163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etanercept in severe, recalcitrant psoriasis: clinical response, safety profile and predictors of response based on a single institution's experience.
    Antoniou C; Dessinioti C; Stratigos A; Avgerinou G; Stavropoulos P; Katsambas A
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):979-82. PubMed ID: 19470056
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dermatitis of the face induced by etretinate].
    Manuzzi P; Reggiani M; Tosti A
    G Ital Dermatol Venereol; 1987 Mar; 122(3):129-30. PubMed ID: 2954901
    [No Abstract]   [Full Text] [Related]  

  • 39. Severe hypoglycemia after initiation of anti-tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2 diabetes mellitus.
    Wambier CG; Foss-Freitas MC; Paschoal RS; Tomazini MV; Simão JC; Foss MC; Foss NT
    J Am Acad Dermatol; 2009 May; 60(5):883-5. PubMed ID: 19389539
    [No Abstract]   [Full Text] [Related]  

  • 40. [Psoriasiform skin reactions during treatment with etanercept].
    Santos-Juanes J; Galache C
    Actas Dermosifiliogr; 2010 May; 101 Suppl 1():106-10. PubMed ID: 20492890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.